This information was published on 2022-10-10T14:20:02 for IP Right Filed Published.
| Field | Value |
| (210) | 2306245 |
| (220) |
10 Oct 2022
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of multiple sclerosis. |
| (540) | CENRIFKI |
| (550) | Word |
| (730) |
Principia Biopharma Inc.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.